Eli Lilly's stock might experience short-term volatility due to its high valuation metrics, which could concern investors wary of overvaluation. However, its strong profitability and revenue growth could counterbalance concerns, maintaining investor interest. The operational efficiency and financial risk highlighted by lower EBITDA, gross profit, and a high debt-to-equity ratio could lead to cautious investor sentiment, impacting short-term stock performance.